angiotensin ii has been researched along with Peripheral Vascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avan, A; Froutagh, MHS; Ghotbani, F; Jamshidi, R; Lotfian, E; Mahaki, H; Mahmoodian, R; Nobari, S; Saki, S; Sheykhhasan, M; Tanzadehpanah, H | 1 |
| Chester, MR; Conant, AR; Dihmis, WC; Oo, AY; Shackcloth, MJ; Simpson, AW | 1 |
| Bradbury, AW; Hobbs, SD; Thomas, ME | 1 |
| Kondo, T; Manabe, I; Matsubara, T; Murohara, T; Nagai, R; Numaguchi, Y; Sata, M; Tsuzuki, M; Yamada, T | 1 |
| McInnes, GT | 1 |
3 review(s) available for angiotensin ii and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Cytokines; Endothelial Cells; Humans; Hypertension; Peripheral Vascular Diseases; SARS-CoV-2 | 2023 |
Manipulation of the renin angiotensin system in peripheral arterial disease.
Topics: Algorithms; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; Humans; Peripheral Vascular Diseases; Ramipril; Renal Artery Obstruction; Renin-Angiotensin System | 2004 |
Role of ACE inhibitors in hypertension complicated by vascular disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Disease; Humans; Hypertension; Peripheral Vascular Diseases | 1994 |
2 other study(ies) available for angiotensin ii and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Phenoxybenzamine treatment is insufficient to prevent spasm in the radial artery: the effect of other vasodilators.
Topics: Adrenergic alpha-Agonists; Aged; Angiotensin II; Coronary Artery Bypass; Diltiazem; Dose-Response Relationship, Drug; Endothelin-1; Humans; Middle Aged; Nitroglycerin; Norepinephrine; Papaverine; Peripheral Vascular Diseases; Phenoxybenzamine; Phosphodiesterase Inhibitors; Radial Artery; Spasm; Time Factors; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2003 |
Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Femoral Artery; Humans; Imidazoles; Mice; Mice, Transgenic; Myocytes, Smooth Muscle; Peripheral Vascular Diseases; Pyridines | 2007 |